Description:
NRF2/AREResponsiveLuciferaseReporterNIH3T3StableCellLineisderivedfromMousefibroblast,andstablyexpressfireflyluciferasereportergeneunderthecontroloftheNRF2/AREresponseelement. ThiscelllineisanidealcellularmodelformonitoringtheactivationofAntioxidantResponsePathwaytriggeredbystimulitreatment,enforcedgeneexpressionandgeneknockdown.Principle:
NRF2playsacrucialroleincellularanti-oxidantdefense,makingitatherapeutictargetforneurodegenerativediseasesandcancer. Undernormalconditions,NRF2localizesinthecytosolandisrapidlydegradedbytheproteasome. Underoxidativestress,NRF2isstABIlizedandtranslocatestothenucleuswhereitbindstoaDNApromoterandinitiatesgeneexpression. Inthenucleus,NRF2formsaheterodimerwithasmallMafproteinandbindstotheAntioxidantResponseElementintheupstreampromoterregionofmanyantioxidativegenes,andinitiatestheirtranscription.
ThisNRF2luciferasereporterstablecelllinehasbeenstablytransfectedwithpTA-ARE-luciferasereportervector,whichcontains4repeatsofantioxidantresponsebindingsites,aminimalpromoterupstreamofthefireflyluciferasecodingregion,alongwitha hygromycinexpressionvector. Followingselection,the hygromycinresistantclonesweresubsequentlyscreenedforTBHQ-inducedluciferaseactivity.Theclonewiththehighestfoldinductionwasselectedandexpandedtoproducethisstablecellline.
PrinciplebehindTFluciferasereporter. TFluciferasereporterstablecelllineutilizesartificialpromoterconstructstodriveluciferaseexpression. Thepromoterregioncanconsistsofmultiplerepeatsofacis-elementTFbindingsite,aDNAfragmentfromthepromoterregionofaknownTFdownstreamgene,oraDNAfragmentcontainingputative/knownTFbindingsites. ThereareseveralwaysthataTFcanbeactivated,suchasthroughextracellularstimuliorthroughintracellularsignalingpathways. Onceactivated,theTFtranslocatestothenucleusandofteninteractswithrelevantco-factorstodrivegeneexpression. Onceluciferaseisexpressed,itcangeneratelightinanenzymaticassayandtheamountoflightmeasuredispositivelycorrelatedwiththelevelofTFactivation. |
Data:
AnalysisoftheNRF2PathwayReporterNIH3T3StableCellLineinresponsetostimuli. Thecellswereseededona96-wellplatefor8hoursorovernightwithDMEMincluding10%FBS.Thecellsthenweretreatedwithorwithout10μMTBHQor10μM4HNE respectivelyinDMEMand0.1%FBSfor16hours.
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
2.将构建完成的载体与慢病毒包装质粒混合,共转染靶细胞
3.收集病毒液
4.用病毒液感染靶细胞
5.用载体上带的抗生素进行筛选,如果没有,可以用无限稀释法
6.获得稳转株
对于瞬时转染的检测:如果有报告基因,就通过报告基因的表达看转染成功与否;没有报告基因的话,就在24~96h内收获细胞通过RT-PCR和WB来鉴定。
然后你得确定,这个细胞株对于你得研究来说不可或缺,具有明确的代表性。
上面两个都没有问题的话,祝你顺利。
由于质粒的不兼容性,拥有同种复制子的质粒不能在同一细胞内稳定共存,经过几代的复制,会质粒丢失,所以并不是任何两个或两个以上质粒都可以在同一细胞内稳定存在,但是可以同时进入.
稳定转染的细胞株,就是转染后质粒可以稳定整合到基因组上不会因细胞分裂而丢失。区别于质粒瞬时转染不能长时间保留质粒在细胞里。
暂无品牌问答